NeurAxis, Inc. (NRXS)
- Previous Close
3.1600 - Open
3.1500 - Bid 1.2700 x 1000
- Ask 3.2000 x 800
- Day's Range
3.0400 - 3.2600 - 52 Week Range
1.8000 - 6.9300 - Volume
214 - Avg. Volume
7,998 - Market Cap (intraday)
21.008M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-2.2100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
neuraxis.comRecent News: NRXS
Performance Overview: NRXS
Trailing total returns as of 5/28/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NRXS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NRXS
Valuation Measures
Market Cap
21.01M
Enterprise Value
22.67M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.05
Price/Book (mrq)
--
Enterprise Value/Revenue
9.85
Enterprise Value/EBITDA
-4.39
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-376.39%
Return on Equity (ttm)
--
Revenue (ttm)
2.3M
Net Income Avi to Common (ttm)
-14.57M
Diluted EPS (ttm)
-2.2100
Balance Sheet and Cash Flow
Total Cash (mrq)
81.75k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-11.19M